— Know what they know.
Not Investment Advice
Also trades as: NEU.AX (ASX) · $vol 8M

NURPF OTC

Neuren Pharmaceuticals Limited
1W: +2.4% 1M: -12.1% 3M: +19.0% YTD: +10.6% 1Y: +19.0% 3Y: +62.8% 5Y: +1313.9%
$14.28
+0.34 (+2.42%)
 
Weekly Expected Move ±6.0%
$13 $13 $14 $15 $16
OTC · Healthcare · Biotechnology · Tech Score Sell · Power 44 · $1.8B mcap · 108M float · 0.0005% daily turnover · Short 67% of daily vol

📊 Key Metrics

TTM
$290M
Revenue
+7.2% YoY
$169M
Net Income
-1.8% YoY
$143M
Free Cash Flow
-17.9% YoY
100.0%
Gross Margin
8.2%
Op. Margin
14.6%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE61.3%
ROA59.6%
ROIC282.5%

Valuation

P/E128.1
P/B7.7
EV/EBITDA0.0

Leverage

Debt/Equity0.00
Current Ratio46.45
Interest Cov.0.0x

Quality Scores

Piotroski F5/9
Altman Z—
Beneish M23.70

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms